Literature DB >> 16473786

Neonatal isolated critical aortic valve stenosis: balloon valvuloplasty or surgical valvotomy.

Zarin Zain1, Mariutzka Zadinello, Samuel Menahem, Christian Brizard.   

Abstract

BACKGROUND: Open surgical valvotomy and transcatheter balloon valvuloplasty are recognised treatments for neonatal critical aortic stenosis.
METHODS: A retrospective analysis was undertaken of all newborns with critical aortic valve stenosis between 1990 and 2000 presenting to a tertiary centre and who required intervention. The initial catheter and surgical intervention was generally based on the preference of the attending cardiologist and the anatomy of the aortic valve and in consultation with the cardiothoracic surgeon. The two groups were therefore not strictly comparable. Twelve were subjected to balloon valvuloplasty and thirteen to surgical valvotomy at a median age of 11 days (2-42 days) and 3.5 days (1-19 days) respectively. There was no significant difference in the timing of the procedure, weight of the infant, aortic annulus or left ventricular dimensions in either group.
RESULTS: There was one unrelated hospital death in the balloon group compared to two in the surgical group both of whom had endocardial fibroelastosis. Mild to moderate aortic regurgitation was seen after both procedures. Four patients in the balloon valvuloplasty group, developed femoral artery thrombosis and two had cardiac perforation that resolved with non operative management. The mean Doppler gradient was reduced from 44+/-14 mmHg to 13.4+/-5 mmHg (p<0.01) in the valvuloplasty group compared to a reduction from 42+/-15 mmHg to 27+/-8 mmHg (p<0.05) in the surgical group. Five patients in the balloon group required re-intervention within 3 weeks to 21 months after the initial procedure. Two patients in the surgical group required a pulmonary autograft and Konno Procedure 3 and 5 years following surgical valvotomy.
CONCLUSION: Both aortic valvuloplasty and valvotomy offered effective short and medium term palliation. Balloon valvuloplasty patients had a higher re-intervention rate but shorter hospital and intensive care stay, reduced immediate morbidity and were associated with less severe aortic regurgitation.

Entities:  

Mesh:

Year:  2005        PMID: 16473786     DOI: 10.1016/j.hlc.2005.02.003

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  6 in total

1.  Exercise function of children with congenital aortic stenosis following aortic valvuloplasty during early infancy.

Authors:  Alaina K Kipps; Doff B McElhinney; Janet Kane; Jonathan Rhodes
Journal:  Congenit Heart Dis       Date:  2009 Jul-Aug       Impact factor: 2.007

2.  A Comparison of Anterograde Versus Retrograde Approaches for Neonatal Balloon Aortic Valvuloplasty.

Authors:  Namrita Mozumdar; Edmund Burke; Melissa Schweizer; Matthew J Gillespie; Yoav Dori; Hari K Narayan; Jonathan J Rome; Andrew C Glatz
Journal:  Pediatr Cardiol       Date:  2017-11-13       Impact factor: 1.655

3.  Left ventricle pseudoaneurysm after aortic valvuloplasty.

Authors:  Abdullah Alhuzaimi; Martin Hosking; Derek Human
Journal:  Pediatr Cardiol       Date:  2011-09-06       Impact factor: 1.655

4.  Results of balloon and surgical valvuloplasty in congenital aortic valve stenosis: A 19-year, single-center, retrospective study.

Authors:  Kahraman Yakut; Niyazi Kürşad Tokel; Birgül Varan; İlkay Erdoğan; Murat Özkan
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-04-26       Impact factor: 0.332

5.  The mid-term outcome of primary open valvotomy for critical aortic stenosis in early infancy - a retrospective single center study over 18 years.

Authors:  Claire Galoin-Bertail; André Capderou; Emre Belli; Lucile Houyel
Journal:  J Cardiothorac Surg       Date:  2016-08-02       Impact factor: 1.637

6.  Balloon aortic valvuloplasty in neonates: short- and long-term effects and predictors of successful outcome.

Authors:  Filip Tyc; Michal Galeczka; Jacek Białkowski; Katarzyna Kulig; Roland Fiszer
Journal:  Postepy Kardiol Interwencyjnej       Date:  2022-08-19       Impact factor: 1.065

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.